Detection of adverse drug events in e-prescribing and administrative health data: a validation study
- PMID: 33892716
- PMCID: PMC8063436
- DOI: 10.1186/s12913-021-06346-y
Detection of adverse drug events in e-prescribing and administrative health data: a validation study
Abstract
Background: Administrative health data are increasingly used to detect adverse drug events (ADEs). However, the few studies evaluating diagnostic codes for ADE detection demonstrated low sensitivity, likely due to narrow code sets, physician under-recognition of ADEs, and underreporting in administrative data. The objective of this study was to determine if combining an expanded ICD code set in administrative data with e-prescribing data improves ADE detection.
Methods: We conducted a prospective cohort study among patients newly prescribed antidepressant or antihypertensive medication in primary care and followed for 2 months. Gold standard ADEs were defined as patient-reported symptoms adjudicated as medication-related by a clinical expert. Potential ADEs in administrative data were defined as physician, ED, or hospital visits during follow-up for known adverse effects of the study medication, as identified by ICD codes. Potential ADEs in e-prescribing data were defined as study drug discontinuations or dose changes made during follow-up for safety or effectiveness reasons.
Results: Of 688 study participants, 445 (64.7%) were female and mean age was 64.2 (SD 13.9). The study drug for 386 (56.1%) patients was an antihypertensive, and for 302 (43.9%) an antidepressant. Using the gold standard definition, 114 (16.6%) patients experienced an ADE, with 40 (10.4%) among antihypertensive users and 74 (24.5%) among antidepressant users. The sensitivity of the expanded ICD code set was 7.0%, of e-prescribing data 9.7%, and of the two combined 14.0%. Specificities were high (86.0-95.0%). The sensitivity of the combined approach increased to 25.8% when analysis was restricted to the 27% of patients who indicated having reported symptoms to a physician.
Conclusion: Combining an expanded diagnostic code set with e-prescribing data improves ADE detection. As few patients report symptoms to their physician, higher detection rates may be achieved by collecting patient-reported outcomes via emerging digital technologies such as patient portals and mHealth applications.
Keywords: Administrative health data; Adverse drug event; Electronic prescribing data; Validation.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Use of ICD-10-CM T codes in hospital claims data to identify adverse drug events in Taiwan.J Clin Pharm Ther. 2021 Apr;46(2):476-483. doi: 10.1111/jcpt.13308. Epub 2020 Nov 18. J Clin Pharm Ther. 2021. PMID: 33210301
-
Validating use of diagnostic codes in Canadian administrative data for identification of adverse drug events.Br J Clin Pharmacol. 2024 Jul;90(7):1688-1698. doi: 10.1111/bcp.16067. Epub 2024 Apr 11. Br J Clin Pharmacol. 2024. PMID: 38604986
-
Adverse Drug Events in Ambulatory Care: A Cross-Sectional Study.Drug Saf. 2025 Apr;48(4):363-374. doi: 10.1007/s40264-024-01501-w. Epub 2024 Dec 2. Drug Saf. 2025. PMID: 39621298
-
Anticoagulation-Associated Adverse Drug Events in Hospitalized Patients Across Two Time Periods.Am J Med. 2023 Sep;136(9):927-936.e3. doi: 10.1016/j.amjmed.2023.05.013. Epub 2023 May 27. Am J Med. 2023. PMID: 37247752 Review.
-
Effect of Electronic Prescribing Strategies on Medication Error and Harm in Hospital: a Systematic Review and Meta-analysis.J Gen Intern Med. 2019 Oct;34(10):2210-2223. doi: 10.1007/s11606-019-05236-8. Epub 2019 Aug 8. J Gen Intern Med. 2019. PMID: 31396810 Free PMC article.
Cited by
-
Co-Designing a Consumer-Focused Digital Reporting Health Platform to Improve Adverse Medicine Event Reporting: Protocol for a Multimethod Research Project (the ReMedi Project).JMIR Res Protoc. 2025 Jan 15;14:e60084. doi: 10.2196/60084. JMIR Res Protoc. 2025. PMID: 39813668 Free PMC article.
-
Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes.Drug Saf. 2023 Nov;46(11):1161-1172. doi: 10.1007/s40264-023-01348-7. Epub 2023 Oct 2. Drug Saf. 2023. PMID: 37783974 Free PMC article.
-
Magnitude and Characteristics of Adverse Drug Events in Saudi Arabia: A Systematic Review.Saudi J Med Med Sci. 2025 Apr-Jun;13(2):79-89. doi: 10.4103/sjmms.sjmms_582_24. Epub 2025 Apr 21. Saudi J Med Med Sci. 2025. PMID: 40352340 Free PMC article. Review.
-
Prescribing Patterns and Impact of Sedatives in Hospitalized Older Adults: A Secondary Analysis of the MedSafer Study.J Am Geriatr Soc. 2025 Jun;73(6):1753-1761. doi: 10.1111/jgs.19437. Epub 2025 Mar 23. J Am Geriatr Soc. 2025. PMID: 40123160 Free PMC article. Clinical Trial.
-
A Narrative Review of Adverse Event Detection, Monitoring, and Prevention in Indian Hospitals.Cureus. 2022 Sep 14;14(9):e29162. doi: 10.7759/cureus.29162. eCollection 2022 Sep. Cureus. 2022. PMID: 36258971 Free PMC article. Review.
References
-
- Canadian Institute for Health Information(CIHI). National Health Expenditure Trends, 1975 to 2017. Ottawa: Canadian Institute for Health Informatin (CIHI); 2017.
-
- Hohl CM, Robitaille C, Lord V, Dankoff J, Colacone A, Pham L, et al. Emergency physician recognition of adverse drug-related events in Elder patients presenting to an emergency department. Acad Emerg Med. 2005;12(3):197–205. 10.1197/j.aem.2004.08.056. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials